1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Point-of-Care Diagnostics Market Outlook 2020
5. Market Segmentation
5.1 By Application
5.2 By Geography
6. Market Drivers and Challenges
6.1 Drivers
6.2 Challenges
7. Industry Trends and Developments
7.1 Portable Ultrasound Providing Care on Site
7.2 Microfluidics Technology Crowding the POCT Industry
8. Competitive Landscape
8.1 Market Share of Major Players
8.2 Key Players
8.2.1 Roche Holding Ltd.
8.2.2 Abbott Laboratories
8.2.3 Johnson and Johnson
8.2.4 Alere
8.2.5 Medtronic
8.2.6 Bayer HealthCare
8.2.7 Siemens HealthCare
8.2.8 Beckman Coulter
8.2.9 Bio-Rad
8.2.10 Becton Dickinson
9. Future Outlook/Market Opportunities

List of Figures

Figure 3-1: Global - Diabetes Incidence (Million), 2014 & 2035
Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2014-2020
Figure 3-3: Global - In Vitro Diagnostic Market by Region (%), 2014
Figure 3-4: Global - In Vitro Diagnostic Market by Region (%), 2020
Figure 3-5: Global - In Vitro Diagnostic Market by Players (%), 2014
Figure 4-1: Global - Share of POCT in the IVD Market (%), 2014 & 2020
Figure 4-2: Global - Point of Care Testing Market (Billion US$), 2014-2020
Figure 5-1: Global - Point of Care Testing Market by Application (%), 2014
Figure 5-2: Global - Point of Care Testing Market by Application (%), 2020
Figure 5-3: Global - Point of Care Testing Market by Players (%), 2014
Figure 8-1: Global - Point-of-Care Testing Market by Players (%), 2014
Figure 8-2: Roche Holdings Ltd - Revenue by Business Segment (%), 2014
Figure 8-3: Abbott Laboratories - Revenue by Business Segment (%), 2014
Figure 8-4: Abbott Laboratories - Revenue by Region (%), 2014
Figure 8-5: Johnson & Johnson - Revenue by Business Segment (%), 2014
Figure 8-6: Johnson & Johnson - Medical Devices and Dx Revenue by Segment (%), 2014
Figure 8-7: Johnson & Johnson - Revenue by Region (%), 2014
Figure 8-8: Johnson & Johnson - Medical Devices and Dx Revenue by Region (%), 2014
Figure 8-9: Alere Inc. - Revenue by Business Segment (%), 2013
Figure 8-10: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2013
Figure 8-11: Medtronic Inc. - Revenue by Business Segment (%), 2014
Figure 8-12: Medtronic Inc. - Revenue by Region (%), 2014
Figure 8-13: Bayer HealthCare - Revenue by Business Segment (%), 2014
Figure 8-14: Bayer HealthCare - Revenue by Business Region (%), 2014
Figure 8-15: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2014
Figure 8-16: Siemens HealthCare - Revenue by Region (%), 2014
Figure 8-17: Siemens HealthCare - Revenue by Business Segment (%), 2014
Figure 8-18: Bio-Rad - Revenue by Segment (%), 2014
Figure 8-19: Bio-Rad - Revenue by Region (%), 2014
Figure 8-20: Becton Dickinson - Revenue by Business Segment (%), 2014
Figure 8-21: Becton Dickinson - Revenue by Region (%), 2014

List of Tables

Table 8-1: Roche Holdings Ltd - POCT Product Portfolio
Table 8-2: Roche Holdings Ltd - Key POCT Product Launches for 2015
Table 8-3: Roche Holdings Ltd - Key Financials (Million CHF), 2012-2014
Table 8-4: Roche Holdings Ltd - Strengths and Weaknesses
Table 8-5: Abbott Laboratories - POCT Product Portfolio
Table 8-6: Abbott Laboratories - Key Financials (Million US$), 2012-2014
Table 8-7: Abbott Laboratories - Strengths and Weaknesses
Table 8-8: Johnson & Johnson - POCT Product Portfolio
Table 8-9: Johnson & Johnson - Key Financials (Million US$), 2012-2014
Table 8-10: Johnson & Johnson - Strengths and Weaknesses
Table 8-11: Alere Inc. - POCT Product Portfolio
Table 8-12: Alere Inc. - Key Financials (Million US$), 2011-2013
Table 8-13: Alere Inc. - Strengths and Weaknesses
Table 8-14: Medtronic Inc. - POCT Product Portfolio
Table 8-15: Medtronic Inc. - Key Financials (Million US$), 2012-2014
Table 8-16: Medtronic Inc. - Strengths and Weaknesses
Table 8-17: Bayer HealthCare - POCT Product Portfolio
Table 8-18: Bayer HealthCare - Key Financials (Million €), 2012-2014
Table 8-19: Bayer HealthCare - Strengths and Weaknesses
Table 8-20: Siemens Healthcare - POCT Product Portfolio
Table 8-21: Siemens Healthcare - Key Financials (Million €), 2012-2014
Table 8-22: Siemens Healthcare - Strength and Weaknesses
Table 8-23: Beckman Coulter - POCT Product Portfolio
Table 8-24: Beckman Coulter - Strengths and Weaknesses
Table 8-25: Bio-Rad - POCT Product Portfolio
Table 8-26: Bio-Rad - Key Financials (Million US$) 2012-2014
Table 8-27: Bio-Rad - Strengths and Weaknesses
Table 8-28: Becton Dickinson - POCT Product Portfolio
Table 8-29: Becton Dickinson - Key Financials (Million US$), 2012-2014
Table 8-30: Becton Dickinson - Strengths and Weaknesses